Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery.
Park Medi World Limited (PARKHOSPS) is listed on the NSE in the Healthcare sector, Medical Care Facilities industry. The PARKHOSPS share price is ₹260.12 (+5.96% today), with a market capitalisation of ₹112B and a price-to-earnings (P/E) ratio of 39.6. MarketRipple tracks the PARKHOSPS investment thesis, the ripple-chain impact of market events on Park Medi World Limited, and the Healthcare sector outlook.
Open
₹260.00
High
₹262.48
Low
₹252.35
Prev. Close
₹245.50
52W High
₹305.00
52W Low
₹138.10
Day range
₹252.35–₹262.48
52-week range
₹138.10–₹305.00
Volume
483K
P/E
39.6
ROE
12.8%
D/E
0.18
Margin
16.1%
Park Medi World Limited (NSE: PARKHOSPS) is currently trading at ₹260.12 (+5.96%).
Park Medi World Limited's market capitalization is ₹112B.
Park Medi World Limited's price-to-earnings (P/E) ratio is 39.6.
Park Medi World Limited operates in the Healthcare sector (Medical Care Facilities).
Analyst consensus on Park Medi World Limited currently reads neutral, based on 2 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.